Skip to main content
Va. biotech Cavion acquired by Jazz Pharmaceuticals

Jazz Pharmaceuticals has acquired Cavion as part of its expansion plans in Philadelphia. The deal will mean an upfront payment of $52.5 million plus additional payments worth up to $260 million upon completion of specific regulatory and commercial milestones that were not disclosed.

Full Story: